Home/Filings/4/0001415889-25-004526
4//SEC Filing

Powell Fred M 4

Accession 0001415889-25-004526

CIK 0001840748other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 8:15 PM ET

Size

5.6 KB

Accession

0001415889-25-004526

Insider Transaction Report

Form 4
Period: 2025-02-13
Powell Fred M
Chief Financial Officer
Transactions
  • Award

    Share Options (Right to Buy)

    2025-02-13+124,700124,700 total
    Exercise: $0.93Exp: 2035-03-12Common Shares (124,700 underlying)
Footnotes (1)
  • [F1]The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date.

Issuer

LAVA Therapeutics NV

CIK 0001840748

Entity typeother

Related Parties

1
  • filerCIK 0001331339

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:15 PM ET
Size
5.6 KB